NCT01164241
- Conditions
- Amyloidosis, Primary Cutaneous, Anaphylaxis, Dermatitis, +15 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
PGM3 Deficiency
Explore clinical trials studying PGM3 Deficiency. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies